Search Results - "Bisaga, Adam"

Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials.

Authors: Shulman, Matisyahu Hu, Mei‐Chen Sullivan, Maria A. et al.

Source: American Journal on Addictions. Nov2025, Vol. 34 Issue 6, p654-662.

Commentary on Ezard et al.: Prescribed psychostimulant medications for methamphetamine use disorder – an urgent path forward.

Authors: Bisaga, Adam

Source: Addiction. Jul2025, Vol. 120 Issue 7, p1360-1362. 3p.

Subjects: Substance abuse, Combination drug therapy, Patient compliance, Methamphetamine, Patient safety, Central nervous system stimulants, Dose-effect relationship in pharmacology, Quality of life, Drugs

Telehealth for opioid use disorder: retention as a function of demographics and rurality.

Authors: Williams, Arthur Robin Aronowitz, Shoshana V. Rowe, Christopher et al.

Source: American Journal of Drug & Alcohol Abuse. 2023, Vol. 49 Issue 2, p260-265.

Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.

Authors: Shulman, Matisyahu Greiner, Miranda Bisaga, Adam

Source: Addiction. Jan2024, Vol. 119 Issue 1, p158-159. 2p.

Subjects: Controlled release drugs, Naltrexone, Substance abuse, Central nervous system stimulants, Narcotic antagonists, Buprenorphine, Disease relapse, Risk assessment, Methamphetamine, Amphetamines, Cocaine, Drugs of abuse, Disease risk factors

Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone.

Authors: Rudolph, Kara E. Inose, Shodai Williams, Nicholas T. et al.

Source: Addiction. Jan2026, Vol. 121 Issue 1, p117-125.

Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism.

Authors: Nunes, Edward V. Bisaga, Adam Krupitsky, Evgeny et al.

Source: Addiction. Nov2020, Vol. 115 Issue 11, p2188-2190. 3p.

Subjects: Cognition, Motivation (Psychology), Naltrexone, Narcotics, Substance abuse

The acute and repeated effects of cigarette smoking and smoking‐related cues on impulsivity.

Authors: Martinez, Suky Jones, Jermaine D. Vadhan, Nehal P. et al.

Source: Drug & Alcohol Review. Jul2021, Vol. 40 Issue 5, p864-868.

Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism.

Authors: Nunes, Edward V. Bisaga, Adam Krupitsky, Evgeny et al.

Source: Addiction. Feb2020, Vol. 115 Issue 2, p239-246.

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.

Authors: Tardelli, Vitor S. Bisaga, Adam Arcadepani, Felipe B. et al.

Source: Psychopharmacology. Aug2020, Vol. 237 Issue 8, p2233-2255.

Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.

Authors: Bisaga, Adam Mannelli, Paolo Sullivan, Maria A. et al.

Source: American Journal on Addictions. Apr2018, Vol. 27 Issue 3, p177-187. 11p. 1 Diagram, 2 Charts.

Subjects: Drug abuse treatment, Opioid abuse, Public health, Health of people with drug addiction, Medical care of people with drug addiction, Management, Substance abuse & psychology, Substance abuse treatment, Substance abuse diagnosis, Analgesics, Compulsive behavior, Drug withdrawal symptoms, Narcotics, Pharmacodynamics

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.

Authors: Sibai, Mohammad Mishlen, Kaitlyn Nunes, Edward V. et al.

Source: American Journal of Drug & Alcohol Abuse. 2020, Vol. 46 Issue 3, p289-296.

Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome.

Authors: Aharonovich, Efrat Garawi, Fatima Bisaga, Adam et al.

Source: American Journal of Drug & Alcohol Abuse. Nov2006, Vol. 32 Issue 4, p629-635.

Open-label pilot study of quetiapine treatment for cannabis dependence.

Authors: Mariani, John J. Pavlicova, Martina Mamczur, Agnieszka K. et al.

Source: American Journal of Drug & Alcohol Abuse. 2014, Vol. 40 Issue 4, p280-284.

A Comparison of Independent Depression and Substance-Induced Depression in Cannabis-, Cocaine-, and Opioid-Dependent Treatment Seekers.

Authors: Dakwar, Elias Nunes, Edward V. Bisaga, Adam et al.

Source: American Journal on Addictions. Sep2011, Vol. 20 Issue 5, p441-446.

Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence.

Authors: Raby, Wilfrid Noel Carpenter, Kenneth M. Rothenberg, Jami et al.

Source: American Journal on Addictions. Jul2009, Vol. 18 Issue 4, p301-308.

Antisocial Behavioral Syndromes in Cocaine and Cannabis Dependence.

Authors: Mariani, John J. Horey, Jonathan Bisaga, Adam et al.

Source: American Journal of Drug & Alcohol Abuse. 2008, Vol. 34 Issue 4, p405-414.

Dextromethorphan and Quinidine Combination for Heroin Detoxification.

Authors: Akerele, Evaristo Bisaga, Adam Sullivan, Maria A. et al.

Source: American Journal on Addictions. May/Jun2008, Vol. 17 Issue 3, p176-180.

Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders.

Authors: Williams, Arthur Robin Barbieri, Vincent Mishlen, Kaitlyn et al.

Source: American Journal on Addictions. Jun2017, Vol. 26 Issue 4, p319-325.

A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.

Authors: Levin, Frances R. Bisaga, Adam Sullivan, Maria A. et al.

Source: American Journal on Addictions. Dec2016, Vol. 25 Issue 8, p603-609.

Toward a public health and prevention‐oriented approach to stimulant‐induced psychosis.

Authors: Bouthillier, Anne Sharafi, Heidar Bisaga, Adam et al.

Source: Addiction. Jun2026, p1. 2p.